BONE FORMATION IN VIVO: COMPARISON OF OSTEOGENESIS BY TRANSPLANTED MOUSE AND HUMAN MARROW STROMAL FIBROBLASTS
- 1 April 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 63 (8) , 1059-1069
- https://doi.org/10.1097/00007890-199704270-00003
Abstract
Marrow stromal fibroblasts (MSFs) are known to contain bone precursor cells. However, the osteogenic potential of human MSFs has been poorly characterized. The aim of this study was to compare the osteogenic capacity of mouse and human MSFs after implantation in vivo. After in vitro expansion, MSFs were loaded into a number of different vehicles and transplanted subcutaneously into immunodeficient mice. Mouse MSFs transplanted within gelatin, polyvinyl sponges, and collagen matrices all formed a capsule of cortical-like bone surrounding a cavity with active hematopoiesis. In transplants of MSFs from transgenic mice harboring type I procollagen-chloramphenicol acetyltransferase constructs, chloramphenicol acetyltransferase activity was maintained for up to 14 weeks, indicating prolonged bone formation by transplanted MSFs. New bone formation by human MSFs was more dependent on both the in vitro expansion conditions and transplantation vehicles. Within gelatin, woven bone was observed sporadically and only after culture in the presence of dexamethasone and L-ascorbic acid phosphate magnesium salt n-hydrate. Consistent bone formation by human MSFs was achieved only within vehicles containing hydroxyapatite/tricalcium phosphate ceramics (HA/TCP) in the form of blocks, powder, and HA/TCP powder-type I bovine fibrillar collagen strips, and bone was maintained for at least 19 weeks. Cells of the new bone were positive for human osteonectin showing their donor origin. HA/TCP powder, the HA/TCP powder-type I bovine fibrillar collagen strips, and HA/TCP powder held together with fibrin were easier to load and supported more extensive osteogenesis than HA/TCP blocks and thus may be more applicable for therapeutic use. In this article, we describe the differences in the requirements for mouse and human MSFs to form bone, and report the development of a methodology for the consistent in vivo generation of extensive bone from human MSFs.Keywords
This publication has 42 references indexed in Scilit:
- Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cellsBone, 1995
- Bone formation by marrow osteogenic cells (MBA-15) is not accompanied by osteoclastogenesis and generation of hematopoietic supportive microenvironmentJournal of Bone and Mineral Research, 1994
- Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic miceJournal of Bone and Mineral Research, 1994
- Preliminary characterization of porcine bone marrow stromal cells: Skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor β, and basic fibroblast growth factorJournal of Bone and Mineral Research, 1993
- Characterization of cells with osteogenic potential from human marrowBone, 1992
- Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells.The Journal of cell biology, 1992
- Osteogenic Stem Cells and the Stromal System of Bone and MarrowClinical Orthopaedics and Related Research, 1989
- Mineralization in in Vitro Cultures of Rabbit Marrow Stromal CellsPublished by Wolters Kluwer Health ,1986
- Bone formation by isolated calvarial osteoblasts in syngeneic and allogeneic transplants: Light microscopic observationsJournal of Anatomy, 1983
- Properties of bone tissue induced by transitional epitheliumBulletin of Experimental Biology and Medicine, 1982